This site is intended for healthcare professionals
Multiple Sclerosis (MS) Learning Zone
Declaration of sponsorship Novartis Pharma AG

Congress highlights

Declaration of sponsorship Novartis Pharma AG
Read time: 60 mins
Last updated:15th Nov 2022
Published:15th Nov 2022

This year, over 8,700 people attended the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), held on the 26th–28th of October 2022.

At the congress, we invited Professor Bernhard Hemmer, Dr Victoria Leavitt and MS patient advocate Dominic Shadbolt to share their highlights and key insights from presentations and discussions at the event. To hear Professor Hemmer’s and Dr Leavitt’s key insights, click play below.

You can explore new research and insights on MS, key medical updates on treatments and patient-related concerns, as well as interviews with experts and people with MS by simply clicking on the register button or log-in link below.

Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

We caught up with experts in multiple sclerosis (MS) to gain key insights into topics of particular interest at the congress. Join Professor Bernhard Hemmer and Dr Victoria Leavitt to hear highlights from presentations and discussions at the congress.

What were some key highlights from ECTRIMS 2022 that you consider important for clinical practice?

Key insights from ECTRIMS 2022 with Dr Victoria Leavitt

1

Read on below to explore further insights, new research and developments at ECTRIMS 2022.

You can explore new research and insights on MS, key medical updates on treatments and patient-related concerns, as well as interviews with experts and people with MS by simply clicking on the register button or log-in link below.

Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

This year, over 8,700 people attended the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), held on the 26th–28th of October 2022.

At the congress, we invited Professor Bernhard Hemmer, Dr Victoria Leavitt and MS patient advocate Dominic Shadbolt to share their highlights and key insights from presentations and discussions at the event. To hear Professor Hemmer’s and Dr Leavitt’s key insights, click play below.

You can explore new research and insights on MS, key medical updates on treatments and patient-related concerns, as well as interviews with experts and people with MS by simply clicking on the register button or log-in link below.

Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest